Safer prescription of drugs: impact of the PREFASEG system to aid clinical decision-making in primary care in Catalonia

Background In 2008, the Institut Català de la Salut (ICS, Catalan Health Institute) implemented a prescription decision support system in its electronic clinical workstation (ECW), which automatically generates online alerts for general practitioners when a possible medication-related problem (MRP) is detected. This tool is known as PREFASEG, and at the time of beginning a new treatment, it automatically assesses the suitability of the treatment for the individual patient. This analysis is based on ongoing treatments, demographic characteristics, existing pathologies, and patient biochemical variables. As a result of the assessment, therapeutic recommendations are provided. The objective of this study is to present the PREFASEG tool, analyse the main alerts that it generates, and determine the degree of alert acceptance. Methods A cross-sectional descriptive study was carried out to analyse the generation of MRP-related alerts detected by PREFASEG during 2016, 2017, and 2018 in primary care (PC) in Catalonia. The number of MRP alerts generated, the drugs involved, and the acceptance/rejection of the alerts were analysed. An alert was considered "accepted" when the medication that generated the alert was not prescribed, thereby following the recommendation given by the tool. The MRP alerts studied were therapeutic duplications, safety alerts issued by the Spanish Medicines Agency, and drugs not recommended for use in geriatrics. The prescriptions issued by 6411 ICS PC physicians who use the ECW and provide their services to 5.8 million Catalans through 288 PC teams were analysed. Results During the 3 years examined, 67.2 million new prescriptions were analysed, for which PREFASEG generated 4,379,866 alerts (1 for every 15 new treatments). A total of 1,222,159 alerts (28%) were accepted. Pharmacological interactions and therapeutic duplications were the most detected alerts, representing 40 and 30% of the total alerts, respectively. The main pharmacological groups involved in the safety alerts were nonsteroidal anti-inflammatory drugs and renin-angiotensin system inhibitors. Conclusions During the period analysed, 28% of the prescriptions wherein a toxicity-related PREFASEG alert was generated led to treatment modification, thereby helping to prevent the generation of potential safety MRPs. However, the tool should be further improved to increase alert acceptance and thereby improve patient safety.

[1]  Sven Schmiedl,et al.  Potentially inappropriate medications in the elderly: the PRISCUS list. , 2010, Deutsches Arzteblatt international.

[2]  T. Fahey,et al.  Electronic prescribing and other forms of technology to reduce inappropriate medication use and polypharmacy in older people: a review of current evidence. , 2012, Clinics in geriatric medicine.

[3]  Jonathan M. Teich,et al.  Grand challenges in clinical decision support , 2008, J. Biomed. Informatics.

[4]  E. Phillips,et al.  Penicillin Allergy Is Not Necessarily Forever. , 2017, JAMA.

[5]  Dina Demner-Fushman,et al.  Extracting drug indication information from structured product labels using natural language processing , 2013, J. Am. Medical Informatics Assoc..

[6]  P. Ruiz-López,et al.  Incidence of adverse events related to health care in Spain: results of the Spanish National Study of Adverse Events , 2008, Journal of Epidemiology & Community Health.

[7]  M. Wallander,et al.  Incidence of hemorrhagic stroke in the general population: validation of data from The Health Improvement Network , 2013, Pharmacoepidemiology and drug safety.

[8]  J. Benes,et al.  The impact of hospitalwide computerized physician order entry on medical errors in a pediatric hospital. , 2005, Journal of pediatric surgery.

[9]  Marc Berg,et al.  Drug safety alert generation and overriding in a large Dutch university medical centre , 2009, Pharmacoepidemiology and drug safety.

[10]  N. Powell,et al.  Challenges of delabelling penicillin allergy , 2021, Drug and Therapeutics Bulletin.

[11]  S D Small,et al.  The costs of adverse drug events in hospitalized patients. Adverse Drug Events Prevention Study Group. , 1998, JAMA.

[12]  C. Richards,et al.  Emergency hospitalizations for adverse drug events in older Americans. , 2011, The New England journal of medicine.

[13]  R. Page,et al.  Inappropriate prescribing in the hospitalized elderly patient: Defining the problem, evaluation tools, and possible solutions , 2010, Clinical interventions in aging.

[14]  Jane M. Young,et al.  Audit and feedback: effects on professional practice and healthcare outcomes. , 2012, The Cochrane database of systematic reviews.

[15]  M. Santana,et al.  [Polypharmacy in frail elderly patients: is deprescribing the answer?]. , 2012, Revista espanola de geriatria y gerontologia.

[16]  Francisco J Farfán Sedano,et al.  Implementation of SNOMED CT to the medicines database of a general hospital. , 2009, Studies in health technology and informatics.

[17]  J. Grimshaw,et al.  Overview of systematic reviews of the effectiveness of reminders in improving healthcare professional behavior , 2012, Systematic Reviews.

[18]  Samy Suissa,et al.  Concurrent use of diuretics, angiotensin converting enzyme inhibitors, and angiotensin receptor blockers with non-steroidal anti-inflammatory drugs and risk of acute kidney injury: nested case-control study , 2013, BMJ.

[19]  R. Haynes,et al.  Effects of computer-based clinical decision support systems on physician performance and patient outcomes: a systematic review. , 1998, JAMA.

[20]  J. Turgeon,et al.  The Dangers of Polypharmacy in Elderly Patients. , 2017, JAMA internal medicine.

[21]  M. Delgado-Rodríguez,et al.  Systematic review and meta-analysis. , 2017, Medicina intensiva.

[22]  Alastair Baker,et al.  Crossing the Quality Chasm: A New Health System for the 21st Century , 2001, BMJ : British Medical Journal.

[23]  D. Bates,et al.  Clinical Decision Support Systems , 1999, Health Informatics.

[24]  L. Hayden,et al.  Ten Commandments for Effective Clinical Decision Support: Making the Practice of Evidence-based Medicine a Reality , 2011 .

[25]  K. Shojania,et al.  The effects of on-screen, point of care computer reminders on processes and outcomes of care. , 2009, The Cochrane database of systematic reviews.

[26]  D. Bates,et al.  The Costs of Adverse Drug Events in Hospitalized Patients , 1997 .

[27]  M. Pirmohamed,et al.  Which drugs cause preventable admissions to hospital? A systematic review. , 2007, British journal of clinical pharmacology.

[28]  Randolph A. Miller,et al.  Focus on health information technology, electronic health records and their financial impact: A framework for evaluating the appropriateness of clinical decision support alerts and responses , 2012, J. Am. Medical Informatics Assoc..

[29]  A. Fleming,et al.  A Meta-Synthesis of Potentially Inappropriate Prescribing in Older Patients , 2014, Drugs & Aging.

[30]  Miriam C.J.M. Sturkenboom,et al.  Electronic Alerts Versus On-Demand Decision Support to Improve Dyslipidemia Treatment: A Cluster Randomized Controlled Trial , 2008, Circulation.

[31]  Roger B. Davis,et al.  Electronic medical record reminders and panel management to improve primary care of elderly patients. , 2011, Archives of internal medicine.

[32]  H. Gardarsdottir,et al.  The High Impact of Penicillin Allergy Registration in Hospitalized Patients. , 2016, The journal of allergy and clinical immunology. In practice.

[33]  E. Balas,et al.  Improving clinical practice using clinical decision support systems: a systematic review of trials to identify features critical to success , 2005, BMJ : British Medical Journal.

[34]  Ermengol Coma,et al.  Effectiveness of electronic point-of-care reminders versus monthly feedback to improve adherence to 10 clinical recommendations in primary care: a cluster randomized clinical trial , 2019, BMC Medical Informatics and Decision Making.

[35]  P. Maurette,et al.  [To err is human: building a safer health system]. , 2002, Annales francaises d'anesthesie et de reanimation.

[36]  R. Payne.  The epidemiology of polypharmacy. , 2016, Clinical medicine.

[37]  V. Hasselblad,et al.  Effect of Clinical Decision-Support Systems , 2012, Annals of Internal Medicine.

[38]  J. Hanlon,et al.  American Geriatrics Society 2019 Updated AGS Beers Criteria® for Potentially Inappropriate Medication Use in Older Adults , 2019, Journal of the American Geriatrics Society.

[39]  T. Payne.  Computer decision support systems. , 2000, Chest.

[40]  M. Pirmohamed,et al.  Adverse drug reactions as cause of admission to hospital: prospective analysis of 18 820 patients , 2004, BMJ : British Medical Journal.

[41]  N. Laird,et al.  Incidence of Adverse Drug Events and Potential Adverse Drug Events: Implications for Prevention , 1995 .

[42]  Publisher's Note , 2018, Anaesthesia.

[43]  L. M. Lucas,et al.  Polypharmacy , 2007, Journal of General Internal Medicine.

[44]  Robyn Tamblyn,et al.  A randomized trial of the effectiveness of on-demand versus computer-triggered drug decision support in primary care. , 2008, Journal of the American Medical Informatics Association : JAMIA.

[45]  J. Feinglass,et al.  The epidemiology of prescribing errors: the potential impact of computerized prescriber order entry. , 2004, Archives of internal medicine.

[46]  Christopher G Chute,et al.  ADEpedia: a scalable and standardized knowledge base of Adverse Drug Events using semantic web technology. , 2011, AMIA ... Annual Symposium proceedings. AMIA Symposium.

[47]  J. Mira,et al.  A study of the prevalence of adverse events in primary healthcare in Spain. , 2012, European journal of public health.

[48]  Hua Xu,et al.  Development and evaluation of an ensemble resource linking medications to their indications , 2013, J. Am. Medical Informatics Assoc..

[49]  L. Kohn,et al.  COMMITTEE ON QUALITY OF HEALTH CARE IN AMERICA , 2000 .

[50]  Paul Gallagher,et al.  STOPP/START criteria for potentially inappropriate prescribing in older people: version 2 , 2014, Age and ageing.

[51]  G. Meyer,et al.  The EU(7)-PIM list: a list of potentially inappropriate medications for older people consented by experts from seven European countries , 2015, European Journal of Clinical Pharmacology.